UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Recycling of carbon dioxide to methanol and derived products - closing the loop

Chemical Society reviews, 2014-12, Vol.43 (23), p.7995-848

2014

Volltextzugriff (PDF)

Integrated CO2 Capture and Conversion to Formate and Methanol: Connecting Two Threads

Accounts of chemical research, 2019-10, Vol.52 (10), p.2892-2903

2019

Volltextzugriff (PDF)

Pirtobrutinib: First Non-covalent Tyrosine Kinase Inhibitor for Treating Relapsed or Refractory Mantle Cell Lymphoma in Adults

Current medicinal chemistry, 2024-01, Vol.31 (30), p.4757-4762

De, Surya K

2024

Volltextzugriff (PDF)

Ganaxolone: First FDA-approved Medicine for the Treatment of Seizures Associated with Cyclin-dependent Kinase-like 5 Deficiency Disorder

Current medicinal chemistry, 2024-01, Vol.31 (4), p.388-392

De, Surya K.

2024

Volltextzugriff (PDF)

Homogeneous Hydrogenation of CO2 and CO to Methanol: The Renaissance of Low‐Temperature Catalysis in the Context of the Methanol Economy

Angewandte Chemie International Edition, 2022-10, Vol.61 (42), p.e202207278-n/a

International ed. in English, 2022

Volltextzugriff (PDF)

Futibatinib: A Potent and Irreversible Inhibitor of Fibroblast Growth Factor Receptors for Treatment of the Bile Duct Cancer

Current medicinal chemistry, 2024-01, Vol.31 (6), p.666-670

De, Surya K.

2024

Volltextzugriff (PDF)

Oteseconazole: First Approved Orally Bioavailable and Selective CYP51 Inhibitor for the Treatment of Patients with Recurrent Vulvovaginal Candidiasis

Current medicinal chemistry, 2023-01, Vol.30 (37), p.4170-4175

De, Surya K

2023

Volltextzugriff (PDF)

Novel Pyrazino[2,3-b] Pyrazines as mTOR Kinase Inhibitors for Treating Cancer and other Diseases

Current medicinal chemistry, 2024-01, Vol.31 (34), p.5657-5659

De, Surya K

2024

Volltextzugriff (PDF)

New Pyrrolopyrimidines as LRRK2 Inhibitors for Treating Parkinson's Disease

Current medicinal chemistry, 2024-01, Vol.31 (33), p.5477-5480

De, Surya K

2024

Volltextzugriff (PDF)

Novel Pyrimidin-4-yl-3-amino-pyrrolo[3,4-c]pyrazoles as Protein Kinase C Inhibitors for Treating Diseases

Current medicinal chemistry, 2024-03, Vol.31 (8), p.1036-1039

De, Surya K.

2024

Volltextzugriff (PDF)

Pyrazolo[4,3-H]quinazolines as Cyclin-dependent Kinase Inhibitors for Treating Cancer

Current medicinal chemistry, 2024-03, Vol.31 (8), p.1040-1043

De, Surya K.

2024

Volltextzugriff (PDF)

Novel Proline Derivatives for Treating COVID-19

Current medicinal chemistry, 2023-01, Vol.30 (12), p.1458-1461

De, Surya K

2023

Volltextzugriff (PDF)

Abrocitinib: First Globally Approved Selective Janus Kinase-1 Inhibitor for the Treatment of Atopic Dermatitis

Current medicinal chemistry, 2023-01, Vol.30 (38), p.4278-4282

De, Surya K

2023

Volltextzugriff (PDF)

First Approval of Elacestrant as a Selective Estrogen Receptor Degrader for the Treatment of Metastatic Breast Cancer

Current medicinal chemistry, 2024-02, Vol.31 (7), p.791-795

De, Surya K.

2024

Volltextzugriff (PDF)

Sotorasib: First Approved KRAS Mutation Inhibitor for the Treatment of Non-small Cell Lung Cancer

Current medicinal chemistry, 2023-01, Vol.30 (9), p.1000-1002

De, Surya K

2023

Volltextzugriff (PDF)

Mitapivat: A Novel Treatment of Hemolytic Anemia in Adults with Pyruvate Kinase Deficiency

Current medicinal chemistry, 2024-01, Vol.31 (6), p.683-687

De, Surya K.

2024

Volltextzugriff (PDF)

How epigenome drives chromatin folding and dynamics, insights from efficient coarse-grained models of chromosomes

PLoS computational biology, 2018-05, Vol.14 (5), p.e1006159-e1006159

2018

Volltextzugriff (PDF)

First Approval of Adagrasib for the Treatment of Non-Small Cell Lung Cancer Harboring a KRASG12C Mutation

Current medicinal chemistry, 2024-01, Vol.31 (3), p.266-272

De, Surya K.

2024

Volltextzugriff (PDF)

Integrative CO2 Capture and Hydrogenation to Methanol with Reusable Catalyst and Amine: Toward a Carbon Neutral Methanol Economy

Journal of the American Chemical Society, 2018-02, Vol.140 (5), p.1580-1583

2018

Volltextzugriff (PDF)

Anthropogenic Chemical Carbon Cycle for a Sustainable Future

Journal of the American Chemical Society, 2011-08, Vol.133 (33), p.12881-12898

2011

Volltextzugriff (PDF)

A review on the oxidation stability of biodiesel

Renewable & sustainable energy reviews, 2014-07, Vol.35, p.136-153

2014

Volltextzugriff (PDF)

First Approval of Pacritinib as a Selective Janus Associated Kinase-2 Inhibitor for the Treatment of Patients with Myelofibrosis

Anti-cancer agents in medicinal chemistry, 2023-01, Vol.23 (12), p.1355-1360

De, Surya K

2023

Volltextzugriff (PDF)

Discovery of Novel Cysteine Protease Inhibitors for the Treatment of Coronavirus (COVID-19)

Current medicinal chemistry, 2024-01, Vol.31 (9), p.1165-1169

De, Surya K

2024

Volltextzugriff (PDF)

Recent Discovery of Peptidomimetics for the Treatment of Coronavirus (COVID-19), Human Coronavirus, and Enteroviruses

Current medicinal chemistry, 2024-01, Vol.31 (10), p.1289-1295

De, Surya K

2024

Volltextzugriff (PDF)

Sustainable treatment of paint industry wastewater: Current techniques and challenges

Journal of environmental management, 2021-10, Vol.296, p.113105-113105, Article 113105

2021

Volltextzugriff (PDF)

1 – 25 von 5.245

Menü

Weitere Dienste

Einstellungen

Recycling of carbon dioxide to methanol and derived products - closing the loop

Integrated CO2 Capture and Conversion to Formate and Methanol: Connecting Two Threads

Pirtobrutinib: First Non-covalent Tyrosine Kinase Inhibitor for Treating Relapsed or Refractory Mantle Cell Lymphoma in Adults

Ganaxolone: First FDA-approved Medicine for the Treatment of Seizures Associated with Cyclin-dependent Kinase-like 5 Deficiency Disorder

Homogeneous Hydrogenation of CO2 and CO to Methanol: The Renaissance of Low‐Temperature Catalysis in the Context of the Methanol Economy

Futibatinib: A Potent and Irreversible Inhibitor of Fibroblast Growth Factor Receptors for Treatment of the Bile Duct Cancer

Oteseconazole: First Approved Orally Bioavailable and Selective CYP51 Inhibitor for the Treatment of Patients with Recurrent Vulvovaginal Candidiasis

Novel Pyrazino[2,3-b] Pyrazines as mTOR Kinase Inhibitors for Treating Cancer and other Diseases

New Pyrrolopyrimidines as LRRK2 Inhibitors for Treating Parkinson's Disease

Novel Pyrimidin-4-yl-3-amino-pyrrolo[3,4-c]pyrazoles as Protein Kinase C Inhibitors for Treating Diseases

Pyrazolo[4,3-H]quinazolines as Cyclin-dependent Kinase Inhibitors for Treating Cancer

Novel Proline Derivatives for Treating COVID-19

Abrocitinib: First Globally Approved Selective Janus Kinase-1 Inhibitor for the Treatment of Atopic Dermatitis

First Approval of Elacestrant as a Selective Estrogen Receptor Degrader for the Treatment of Metastatic Breast Cancer

Sotorasib: First Approved KRAS Mutation Inhibitor for the Treatment of Non-small Cell Lung Cancer

Mitapivat: A Novel Treatment of Hemolytic Anemia in Adults with Pyruvate Kinase Deficiency

How epigenome drives chromatin folding and dynamics, insights from efficient coarse-grained models of chromosomes

First Approval of Adagrasib for the Treatment of Non-Small Cell Lung Cancer Harboring a KRASG12C Mutation

Integrative CO2 Capture and Hydrogenation to Methanol with Reusable Catalyst and Amine: Toward a Carbon Neutral Methanol Economy

Anthropogenic Chemical Carbon Cycle for a Sustainable Future

A review on the oxidation stability of biodiesel

First Approval of Pacritinib as a Selective Janus Associated Kinase-2 Inhibitor for the Treatment of Patients with Myelofibrosis

Discovery of Novel Cysteine Protease Inhibitors for the Treatment of Coronavirus (COVID-19)

Recent Discovery of Peptidomimetics for the Treatment of Coronavirus (COVID-19), Human Coronavirus, and Enteroviruses

Sustainable treatment of paint industry wastewater: Current techniques and challenges

Suchergebnisse filtern